Stock listing
IRD Stock Price, News, Filings & Events — Opus Genetics, Inc.
Selected listing: IRD · NASDAQ · USD · US
This page tracks Opus Genetics, Inc.'s IRD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IRD:NASDAQ. IRD:NASDAQ is the stock-level entry point for investors researching Opus Genetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Opus Genetics, Inc. is a public company traded under the ticker IRD in the American market. The company has a market capitalization of approximately $254.3 million. Opus Genetics focuses on developing innovative solutions in the field of genetic medicine.
- Ticker
- IRD:NASDAQ
- Asset type
- Stock
- Market cap
- $502.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Opus Genetics, Inc. IRD:NASDAQ stock context
This page tracks Opus Genetics, Inc.'s IRD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IRD:NASDAQ. IRD:NASDAQ is the stock-level entry point for investors researching Opus Genetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Opus Genetics, Inc. is a public company traded under the ticker IRD in the American market. The company has a market capitalization of approximately $254.3 million. Opus Genetics focuses on developing innovative solutions in the field of genetic medicine.
Latest news from Opus Genetics, Inc.
Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting wit...
September 9, 2026
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
August 6, 2026
Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease
August 3, 2026
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
July 9, 2026
Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease
July 6, 2026
Research Opus Genetics, Inc.
Opus Genetics, Inc. investor report
Review AI stock analysis and investor report context for IRD:NASDAQ.
Opus Genetics, Inc. company profile
View the public company page for Opus Genetics, Inc. on 6ix.
Opus Genetics, Inc. news
Read company news and market updates connected to Opus Genetics, Inc..
Opus Genetics, Inc. investor events
Find investor webinars, events, and replay context for Opus Genetics, Inc..
Alternate listings
R3X1:GETTEX
DE · EUR
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.
A2QG4Z:LSX
DE · EUR
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.
R3X1:FWB
DE · EUR
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.
A2QG4Z:LS
DE · EUR
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.
IRD:BOATS
US · USD
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.
R3X1:TRADEGATE
DE · EUR
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.
R3X1:DUS
DE · EUR
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.
R3X1:MUN
DE · EUR
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.
R3X1:SWB
DE · EUR
Alternate listing for Opus Genetics, Inc.; the primary context on this page is IRD:NASDAQ.